Assessing subgroup effects with binary data: can the use of different effect measures lead to different conclusions?
Open Access
- 29 April 2005
- journal article
- Published by Springer Nature in BMC Medical Research Methodology
- Vol. 5 (1) , 15
- https://doi.org/10.1186/1471-2288-5-15
Abstract
Background: In order to use the results of a randomised trial, it is necessary to understand whether the overall observed benefit or harm applies to all individuals, or whether some subgroups receive more benefit or harm than others. This decision is commonly guided by a statistical test for interaction. However, with binary outcomes, different effect measures yield different interaction tests. For example, the UK Hip trial explored the impact of ultrasound of infants with suspected hip dysplasia on the occurrence of subsequent hip treatment. Risk ratios were similar between subgroups defined by level of clinical suspicion (P = 0.14), but odds ratios and risk differences differed strongly between subgroups (P < 0.001). Discussion: Interaction tests on different effect measures differ because they test different null hypotheses. A graphical technique demonstrates that the difference arises when the subgroup risks differ markedly. We consider that the test of interaction acts as a check on the applicability of the trial results to all included subgroups. The test of interaction should therefore be applied to the effect measure which is least likely a priori to exhibit an interaction. We give examples of how this might be done. Summary: The choice of interaction test is especially important when the risk of a binary outcome varies widely between subgroups. The interaction test should be pre-specified and should be guided by clinical knowledge.Keywords
This publication has 19 references indexed in Scilit:
- Statistics Notes: Interaction revisited: the difference between two estimatesBMJ, 2003
- Overview of the main outcomes in breast-cancer prevention trialsThe Lancet, 2003
- Issues in the selection of a summary statistic for meta‐analysis of clinical trials with binary outcomesStatistics in Medicine, 2002
- Stratification Issues with Binary EndpointsDrug Information Journal, 2001
- A graphical display useful for meta-analysisEuropean Journal of Public Health, 1997
- Statistics notes: Interaction 3: How to examine heterogeneityBMJ, 1996
- Statistics Notes: Interaction 2: compare effect sizes not P valuesBMJ, 1996
- Statistics Notes: Interaction 1: heterogeneity of effectsBMJ, 1996
- The number needed to treat: a clinically useful measure of treatment effectBMJ, 1995
- A Consumer's Guide to Subgroup AnalysesAnnals of Internal Medicine, 1992